Logo image
Treatment of rectal chlamydia infection may be more complicated than we originally thought
Journal article   Peer reviewed

Treatment of rectal chlamydia infection may be more complicated than we originally thought

Jane S Hocking, Fabian Y S Kong, Peter Timms, Wilhelmina M Huston and Sepehr N Tabrizi
Journal of Antimicrobial Chemotherapy, Vol.70(4), pp.961-964
2014
url
https://doi.org/10.1093/jac/dku493View
Published Version

Abstract

azithromycin doxycycline treatment failure
Rectal chlamydia diagnoses have been increasing among MSM and may also rise among women as anal sex rates increase among heterosexuals. However, there is growing concern about treatment for rectal chlamydia with treatment failures of up to 22% being reported. This article addresses factors that may be contributing to treatment failure for rectal chlamydia, including the pharmacokinetic properties of azithromycin and doxycycline in rectal tissue, the ability of chlamydia to transform into a persistent state that is less responsive to antimicrobial therapy, the impact of the rectal microbiome on chlamydia, heterotypic resistance, failure to detect cases of lymphogranuloma venereum and the performance of screening tests. If we are to reduce the burden of genital chlamydia, treatment for rectal chlamydia must be efficacious. This highlights the need for randomized controlled trial evidence comparing azithromycin with doxycycline for the treatment of rectal chlamydia.

Details

Metrics

10 File views/ downloads
597 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Web Of Science research areas
Infectious Diseases
Microbiology
Pharmacology & Pharmacy

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Logo image